US RNA-based drug discovery company Arcturus Therapeutics has resumed rights to its flagship...
- CureVac withdraws from part of its RNA drug collaboration with Arcturus
- antiSMASH: on the hunt for new antibiotics
- No-deal Brexit could put UK patients at risk of fake medicines
- The Petri dish: telling the story of pharma’s most humble ally
- JP Morgan: no expert consensus on 2019 capital outlook for bio/pharma
Qualification of Equipment as Part of Process Validation for Medical Devices
An essential part of quality management according to the General Medicine Act (MPG)
and the US Food and Drug Administration's (FDA) Code of Federal Regulations (CFR), is the validation of all processes, and equipment/computer-controlled systems which have a direct impact on the quality of product manufacturing.
CureVac withdraws from part of its RNA drug collaboration with Arcturus
US RNA-based drug discovery company Arcturus Therapeutics has resumed rights to its flagship product ARCT-810 indicated for ornithine transcarbamylase (OTC) deficiency.
Pharmaceutical packaging in 2019: the view from Origin’s Rich Quelch
The pharmaceutical packaging market is always challenging and 2019 will be no exception. What will rising demand from emerging economies, ageing demographics, new technologies and drug discoveries mean for pharmaceutical packaging in 2019? Rich Quelch, Global Head of Marketing, Origin gives his predictions.
Zenith Technologies’ Virtual Manufacturing System Training Service
Zenith Technologies' virtual customised training service tackles critical gaps in industry manufacturing software and process training.
antiSMASH: on the hunt for new antibiotics
Online tool antiSMASH is being used by scientists on the hunt for interesting bacterial metabolites with potential uses for creating new antibiotics, and its accompanying database was recently updated to bring its content up to 25,000 bacterial genomes. antiSMASH co-developer Kai Blin discusses the software and its benefits, as well as the advantages of open-source software design.
In the packaging business, time-to-market is critical. A new product has to be able to be packaged without losing any time and it must be possible to respond within a very short time to marketing or customer requirements.
Insulin delivering drug capsule could replace injections
A research team led by the Massachusetts Institute of Technology (MIT) in the US has developed a pill for oral delivery of insulin, potentially enabling type 2 diabetes patients to replace their daily injections.
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.